SecBot SecBot
8-K ·Filed Apr 9, 2026

CCCC

C4 Therapeutics, Inc.
BULLISH
Impact 7/10
Horizonmonths Processed7mo ago SEC0001628280-26-024336
8-K material event: Items 1.01
Actionable Insight ▲ Bullish

The significant upfront payment and substantial milestone potential provide non-dilutive funding for C4T's pipeline development. The partnership with Roche validates C4T's technology platform. The deal structure with Roche's right to terminate for convenience introduces some execution risk.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$2.83
T+0 close · Apr 9, 2026 · via day close
Latest settled
+46.29%
T+60 · $4.14
Vs SPY
+35.51%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 9 $2.83entry
  2. T+1 · 7mo ago −10.42%α −10.36% · $2.54
  3. T+5 · 7mo ago +2.47%α −0.71% · $2.90
  4. T+20 · 6mo ago +3.53%α −4.03% · $2.93
  5. T+60 · 4mo ago +46.29%α +35.51% · $4.14
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

C4 Therapeutics entered a research collaboration and license agreement with Roche to develop degrader-antibody conjugates (DACs) for two undisclosed oncology targets, with an option for a third. The deal includes a $20 million upfront payment and over $1 billion in potential milestone payments plus royalties. This partnership leverages C4T's TORPEDO platform and Roche's ADC expertise.

Key Financial Metrics

Deal Value
$20.0M
Deal Type
partnership

Key Facts

  • C4 Therapeutics and Roche entered a collaboration agreement for degrader-antibody conjugates (DACs)
  • Roche will develop, manufacture, and commercialize DACs directed to two initial undisclosed oncology targets
  • C4T receives $20 million upfront payment
  • C4T is eligible to receive over $1.0 billion in aggregate milestone payments
  • C4T will receive tiered royalties on net sales ranging from mid-single digit to low-double digit percent
  • Roche has the right to terminate the agreement for convenience with 90 days notice

Financial Impact

$20 million upfront payment and over $1.0 billion in potential milestone payments

revenuecash_flowdilution

Risk Factors

  • Roche can terminate the agreement for convenience with 90 days notice
  • The success of the collaboration depends on achieving specified research and development milestones
  • The upfront payment is modest compared to the potential milestone payments

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-024336
Document: aprilcorporatedeck_final.htm0001628280-26-024336
Document: cccc-20260409xexx991.htm0001628280-26-024336
Document: 0001628280-26-024336-index-headers.html0001628280-26-024336
Document: 0001628280-26-024336-index.html0001628280-26-024336
Document: 0001628280-26-024336.txt0001628280-26-024336

Track record

19 reports on CCCC

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +46.29% at T+60 after the Apr 9, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $2.71 Now $2.65 −2.03% settles Nov 23
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $2.76 Now $2.65 −3.99% settles Nov 20
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $3.10 to $2.76 Now $2.65 −14.52% ▼ −10.97% −13.56% vs SPY
  4. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $2.95 to $2.77 Now $2.65 −10.17% ▼ −6.10% −9.39% vs SPY
  6. Sep 25, 20267w ago 8-K Neutral 4/10 Entry $2.98 to $2.95 Now $2.65 −11.07% ▼ −1.01% −0.79% vs SPY
  7. Sep 25, 20267w ago Press Release Neutral 4/10 Entry $2.98 to $2.95 Now $2.65 −11.07% ▼ −1.01% −0.79% vs SPY
  8. Aug 14, 202613w ago 144 Neutral 3/10 Entry $4.27 to $4.10 Now $2.65 −37.87% ▼ −3.87% −2.68% vs SPY
  9. Aug 14, 202613w ago Institutional Cluster Bullish 6/10 Entry $4.27 to $4.10 Now $2.65 −37.87% ▼ −3.87% −2.68% vs SPY
  10. Aug 11, 202613w ago 8-K Neutral 5/10 Entry $3.87 to $4.18 Now $2.65 −31.52% ▲ +8.01% +8.41% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 9, 2026